1,369 results on '"SORIANO, Alex"'
Search Results
2. Report of three azole-resistant Aspergillus fumigatus cases with TR34/L98H mutation in hematological patients in Barcelona, Spain
3. K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact
4. Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices
5. Multiplex real-time PCR FilmArray performance in the diagnosis of meningoencephalitis: lights and shadows
6. Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignancies
7. Description of reinfection of joint prosthesis after 2-stage replacement (infection of the 2nd stage prosthesis): A multicenter study
8. Caracterización de la reinfección de prótesis articular tras recambio en 2 tiempos (infección de la prótesis del 2.o tiempo). Un estudio multicéntrico
9. Safety and effectiveness of isavuconazole in real-life non-neutropenic patients
10. Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study
11. Performance of an Autonomous Sanitary Sterilisation Ultraviolet Machine (ASSUM) on terminal disinfection of surgical theaters and rooms of an intensive-intermediate care unit
12. Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022
13. Clinical evaluation of antifungal de-escalation in Candida infections: A systematic review and meta-analysis
14. Assessing the influence of the COVID-19 pandemic on the incidence, clinical presentation, and clindamycin resistance rates of Streptococcus pyogenes infections
15. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial
16. Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
17. Staphylococcus aureus surgical site infection rates in 5 European countries
18. Antimicrobials in polymethylmethacrylate: from prevention to prosthetic joint infection treatment: basic principles and risk of resistance
19. Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses
20. Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series
21. Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
22. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials
23. Impact of Positive Cultures During the Second Stage of a Two-Stage Exchange: Systematic Review and Meta-Analysis
24. Prevalence and Impact of Unexpected Positive Intraoperative Cultures in Total Hip or Knee Revision Surgery
25. Rezafungin versus Caspofungin in a Phase 2, Randomized, Double-Blind Study for the Treatment of Candidemia and Invasive Candidiasis- The STRIVE Trial
26. The Use and Effectiveness of Ceftazidime–Avibactam in Real-World Clinical Practice: EZTEAM Study
27. Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel
28. Is an isolated positive sonication fluid culture in revision arthroplasties clinically relevant?
29. Prevention and treatment of C. difficile in cancer patients
30. Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study
31. Role of bacterial colonisation of vancomycin–gentamicin spacers in two-stage arthroplasty revision surgery: the usefulness of spacer sonication
32. Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
33. Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort
34. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
35. The Orthopaedic Device Infection Network: Building an Evidence Base for the Treatment of Periprosthetic Joint Infection Through International Collaboration
36. The Management of Patients at High Risk of Serious COVID-19 Disease: Optimising the Patient Pathway in the Middle East, Africa, and Eastern Europe
37. SAFETY AND IMMUNOGENICITY OF A PHH-1V BOOSTER DOSE AFTER DIFFERENT PRIME VACCINATION SCHEMES AGAINST COVID-19: PHASE III CLINICAL TRIAL FINAL RESULTS UP TO ONE YEAR
38. Emergence of carbapenem-resistant Pseudomonas aeruginosa ST179 producing both IMP-16 and KPC-2: a case study of introduction from Peru to Spain
39. Role of routine suppressive antibiotic therapy after DAIR for acute periprosthetic joint infections
40. An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis
41. Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study
42. Stool donor recruitment – A one-year experience
43. First-generation oral antivirals against SARS-CoV-2
44. Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients
45. Do Cultures Obtained During Primary THA Predict the Likelihood of Revision?
46. Bacterial co-infection at hospital admission in patients with COVID-19
47. Lack of Prognostic Value of SARS-CoV2 RT-PCR Cycle Threshold in the Community
48. Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
49. C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
50. Recommendations for stool donor selection for fecal microbiota transplant. Consensus document endorsed by the Catalan Society of Digestology, Catalan Society of Infectious diseases and Clinical Microbiology and the GEMBIOTA group from Spanish Society of Infectious Diseases and Clinical Microbiology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.